These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 9736741)

  • 41. Adaptation to promiscuous usage of CC and CXC-chemokine coreceptors in vivo correlates with HIV-1 disease progression.
    Xiao L; Rudolph DL; Owen SM; Spira TJ; Lal RB
    AIDS; 1998 Sep; 12(13):F137-43. PubMed ID: 9764773
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Coreceptor utilization of HIV type 1 subtype E viral isolates from Thai men with HIV type 1-infected and uninfected wives.
    Utaipat U; Duerr A; Rudolph DL; Yang C; Butera ST; Lupo D; Pisell T; Tangmunkongvorakul A; Kamtorn N; Nantachit N; Nagachinta T; Suriyanon V; Robison V; Nelson KE; Sittisombut N; Lal RB
    AIDS Res Hum Retroviruses; 2002 Jan; 18(1):1-11. PubMed ID: 11804551
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Replication-competent variants of human immunodeficiency virus type 2 lacking the V3 loop exhibit resistance to chemokine receptor antagonists.
    Lin G; Bertolotti-Ciarlet A; Haggarty B; Romano J; Nolan KM; Leslie GJ; Jordan AP; Huang CC; Kwong PD; Doms RW; Hoxie JA
    J Virol; 2007 Sep; 81(18):9956-66. PubMed ID: 17609282
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Amino acid 324 in the simian immunodeficiency virus SIVmac V3 loop can confer CD4 independence and modulate the interaction with CCR5 and alternative coreceptors.
    Pöhlmann S; Davis C; Meister S; Leslie GJ; Otto C; Reeves JD; Puffer BA; Papkalla A; Krumbiegel M; Marzi A; Lorenz S; Münch J; Doms RW; Kirchhoff F
    J Virol; 2004 Apr; 78(7):3223-32. PubMed ID: 15016843
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Changes in the extracellular envelope glycoprotein of variants that evolve during the course of simian immunodeficiency virus SIVMne infection affect neutralizing antibody recognition, syncytium formation, and macrophage tropism but not replication, cytopathicity, or CCR-5 coreceptor recognition.
    Rudensey LM; Kimata JT; Long EM; Chackerian B; Overbaugh J
    J Virol; 1998 Jan; 72(1):209-17. PubMed ID: 9420217
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Differential CD4/CCR5 utilization, gp120 conformation, and neutralization sensitivity between envelopes from a microglia-adapted human immunodeficiency virus type 1 and its parental isolate.
    Martín J; LaBranche CC; González-Scarano F
    J Virol; 2001 Apr; 75(8):3568-80. PubMed ID: 11264346
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Differential utilization of CCR5 by macrophage and T cell tropic simian immunodeficiency virus strains.
    Edinger AL; Amedee A; Miller K; Doranz BJ; Endres M; Sharron M; Samson M; Lu ZH; Clements JE; Murphey-Corb M; Peiper SC; Parmentier M; Broder CC; Doms RW
    Proc Natl Acad Sci U S A; 1997 Apr; 94(8):4005-10. PubMed ID: 9108095
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Role of the HIV type 1 glycoprotein 120 V3 loop in determining coreceptor usage.
    Verrier F; Borman AM; Brand D; Girard M
    AIDS Res Hum Retroviruses; 1999 May; 15(8):731-43. PubMed ID: 10357469
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Novel Strategy To Adapt Simian-Human Immunodeficiency Virus E1 Carrying
    Scinto HB; Gupta S; Thorat S; Mukhtar MM; Griffiths A; Delgado J; Plake E; Vyas HK; Strickland A; Byrareddy SN; Montefiori DC; LaBranche C; Pal R; Treece J; Orndorff S; Ferrari MG; Weiss D; Chenine AL; McLinden R; Michael N; Kim JH; Robb ML; Rerks-Ngarm S; Pitisuttithum P; Nitayaphan S; Ruprecht RM
    J Virol; 2018 Jul; 92(14):. PubMed ID: 29743361
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Determinants of entry cofactor utilization and tropism in a dualtropic human immunodeficiency virus type 1 primary isolate.
    Smyth RJ; Yi Y; Singh A; Collman RG
    J Virol; 1998 May; 72(5):4478-84. PubMed ID: 9557745
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Coreceptor-dependent inhibition of the cell fusion activity of simian immunodeficiency virus Env proteins.
    Yang C; Yang Q; Compans RW
    J Virol; 2000 Jul; 74(13):6217-22. PubMed ID: 10846110
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Simian immunodeficiency virus utilizes human and sooty mangabey but not rhesus macaque STRL33 for efficient entry.
    Pöhlmann S; Lee B; Meister S; Krumbiegel M; Leslie G; Doms RW; Kirchhoff F
    J Virol; 2000 Jun; 74(11):5075-82. PubMed ID: 10799581
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Coreceptor tropism can be influenced by amino acid substitutions in the gp41 transmembrane subunit of human immunodeficiency virus type 1 envelope protein.
    Huang W; Toma J; Fransen S; Stawiski E; Reeves JD; Whitcomb JM; Parkin N; Petropoulos CJ
    J Virol; 2008 Jun; 82(11):5584-93. PubMed ID: 18353956
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Pathogenic determinants of the mucosally transmissible CXCR4-specific SHIV(SF33A2) map to env region.
    Harouse JM; Gettie A; Tan RC; Eshetu T; Ratterree M; Blanchard J; Cheng-Mayer C
    J Acquir Immune Defic Syndr; 2001 Jul; 27(3):222-8. PubMed ID: 11464140
    [TBL] [Abstract][Full Text] [Related]  

  • 55. HIV-1 R5 Macrophage-Tropic Envelope Glycoprotein Trimers Bind CD4 with High Affinity, while the CD4 Binding Site on Non-macrophage-tropic, T-Tropic R5 Envelopes Is Occluded.
    Quitadamo B; Peters PJ; Repik A; O'Connell O; Mou Z; Koch M; Somasundaran M; Brody R; Luzuriaga K; Wallace A; Wang S; Lu S; McCauley S; Luban J; Duenas-Decamp M; Gonzalez-Perez MP; Clapham PR
    J Virol; 2018 Jan; 92(2):. PubMed ID: 29118121
    [TBL] [Abstract][Full Text] [Related]  

  • 56. CD4-Dependent and CD4-independent utilization of coreceptors by human immunodeficiency viruses type 2 and simian immunodeficiency viruses.
    Liu HY; Soda Y; Shimizu N; Haraguchi Y; Jinno A; Takeuchi Y; Hoshino H
    Virology; 2000 Dec; 278(1):276-88. PubMed ID: 11112502
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Coreceptor competition for association with CD4 may change the susceptibility of human cells to infection with T-tropic and macrophagetropic isolates of human immunodeficiency virus type 1.
    Lee S; Lapham CK; Chen H; King L; Manischewitz J; Romantseva T; Mostowski H; Stantchev TS; Broder CC; Golding H
    J Virol; 2000 Jun; 74(11):5016-23. PubMed ID: 10799575
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Primary human immunodeficiency virus type 2 (HIV-2) isolates, like HIV-1 isolates, frequently use CCR5 but show promiscuity in coreceptor usage.
    Mörner A; Björndal A; Albert J; Kewalramani VN; Littman DR; Inoue R; Thorstensson R; Fenyö EM; Björling E
    J Virol; 1999 Mar; 73(3):2343-9. PubMed ID: 9971817
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Alternative coreceptor requirements for efficient CCR5- and CXCR4-mediated HIV-1 entry into macrophages.
    Cashin K; Roche M; Sterjovski J; Ellett A; Gray LR; Cunningham AL; Ramsland PA; Churchill MJ; Gorry PR
    J Virol; 2011 Oct; 85(20):10699-709. PubMed ID: 21835796
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Coreceptor usage of sequential isolates from cynomolgus monkeys experimentally Infected with simian immunodeficiency virus (SIVsm).
    Vödrös D; Thorstensson R; Biberfeld G; Schols D; De Clercq E; Fenyö EM
    Virology; 2001 Dec; 291(1):12-21. PubMed ID: 11878872
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.